HPS Pharmacies wish to advise that Generic Health, in consultation with the Therapeutic Goods Administration (TGA), has issued a Product Defect Alert for Fentanyl GH 100mcg/2mL as follows:

Fentanyl GH

Fentanyl 100mcg/2mL

ARTG 201872

This notice was issued following a report of one box of Fentanyl GH 100mcg/2mL containing four ampoules of fentanyl and one ampoule of Heparin sodium 5000IU/1mL.

The only batch affected by this defect alert is batch 10450.

Generic Health advises healthcare professionals to open any boxes of Fentanyl GH 100mcg/2mL from this batch before dispensing to confirm that all five ampoules are the correct product.

Please inspect your stock and quarantine all affected products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Generic Health on (03) 9809 7900 or your pharmacist at HPS Pharmacies.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates